Structure and Characteristics of Diabetes Self-management Applications

Angelini, Sara; Alicastro, Gregorio Marco; Dionisi, Sara; M, Di Muzio

doi:10.1097/cin.0000000000000526

Cited by 15 publications

(13 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the mHealth apps that were installed, 35.8% focused on T1DM, 47.6% on T2DM, and 32.0% on GDM [29]. DM-specific mHealth apps exist in great variety and include different features [31]. Possible app features include tracking of blood glucose levels or insulin usage; calculation of insulin dosages; monitoring of diet, body weight, or physical activities; or providing education or information [3,29,30,[32][33][34][35][36][37][38].…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review

Eberle¹,

Löhnert²,

Stichling³

2021

JMIR Mhealth Uhealth

View full text Add to dashboard Cite

Background According to the World Health Organization, the worldwide prevalence of diabetes mellitus (DM) is increasing dramatically and DM comprises a large part of the global burden of disease. At the same time, the ongoing digitalization that is occurring in society today offers novel possibilities to deal with this challenge, such as the creation of mobile health (mHealth) apps. However, while a great variety of DM-specific mHealth apps exist, the evidence in terms of their clinical effectiveness is still limited. Objective The objective of this review was to evaluate the clinical effectiveness of mHealth apps in DM management by analyzing health-related outcomes in patients diagnosed with type 1 DM (T1DM), type 2 DM (T2DM), and gestational DM. Methods A scoping review was performed. A systematic literature search was conducted in MEDLINE (PubMed), Cochrane Library, EMBASE, CINAHL, and Web of Science Core Collection databases for studies published between January 2008 and October 2020. The studies were categorized by outcomes and type of DM. In addition, we carried out a meta-analysis to determine the impact of DM-specific mHealth apps on the management of glycated hemoglobin (HbA1c). Results In total, 27 studies comprising 2887 patients were included. We analyzed 19 randomized controlled trials, 1 randomized crossover trial, 1 exploratory study, 1 observational study, and 5 pre-post design studies. Overall, there was a clear improvement in HbA1c values in patients diagnosed with T1DM and T2DM. In addition, positive tendencies toward improved self-care and self-efficacy as a result of mHealth app use were found. The meta-analysis revealed an effect size, compared with usual care, of a mean difference of –0.54% (95% CI –0.8 to –0.28) for T2DM and –0.63% (95% CI –0.93 to –0.32) for T1DM. Conclusions DM-specific mHealth apps improved the glycemic control by significantly reducing HbA1c values in patients with T1DM and T2DM patients. In general, mHealth apps effectively enhanced DM management. However, further research in terms of clinical effectiveness needs to be done in greater detail.

show abstract

Section: Introductionmentioning

confidence: 99%

Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review

Eberle¹,

Löhnert²,

Stichling³

2021

JMIR Mhealth Uhealth

View full text Add to dashboard Cite

show abstract

“…The mHealth allows us to personalize patient care, improve communication between professionals, and provide a technological advancement that facilitates remote care while reducing its costs [ 32 , 33 ]. In fact, the European Commission estimated already in 2017 that the use of these technologies would save about 99 billion euros, recommending its development [ 1 ].…”

Section: Discussionmentioning

confidence: 99%

The Use of mHealth in Orthopedic Surgery: A Scoping Review

Dionisi

Giannetta

Simone

et al. 2021

IJERPH

Self Cite

View full text Add to dashboard Cite

(1) Background: It is well known that the success of surgical procedures is related to optimal postoperative management and follow-up. In this regard, mHealth technologies could potentially improve perioperative care. Based on these considerations, the objective of this scoping review is to evaluate the current status and use of mHealth interventions designed to provide perioperative care in orthopedic surgery. (2) Methods: This scoping review was conducted in accordance with the PRISMA statement (Extension for Scoping Review) and follows the framework of Arskey and O’Malley. (3) Results: The use of mHealth in the surgical setting is mainly oriented towards the development of applications for monitoring post-operative pain and optimizing communication between the various health professionals involved in patient care. (4) Conclusions: The mHealth systems can have a positive impact both on patient participation in the therapeutic process and on the communication between health professionals, increasing the quality of care.

show abstract

“…Diabetes apps vary in their range of considered topics and features [9,10,12,13,16,17,[80][81][82]. Common features include tracking of blood glucose levels or insulin usage, calculating an insulin dose, monitoring of diet, weight or physical activity, providing education, or allowing communication and exchange of data with health care professionals or social networks [2,[8][9][10][11][12][13][14][15][16][17][80][81][82][83][84].…”

Section: Mhealth Appsmentioning

confidence: 99%

“…Features such as writing a digital diary instead of a standard paper diary are not considered to affect QoL [92]. However, because of the combination of different features in most apps, it is difficult to determine the impact of specific app features on clinical outcomes [8]. Diabetes apps are supposed to improve glycemic control through significant reduction of HbA 1c , although evidence on safety and effectiveness is limited, especially regarding long-term outcomes [93][94][95].…”

Section: Mhealth Appsmentioning

confidence: 99%

See 1 more Smart Citation

Diabetology 4.0: Scoping Review of Novel Insights and Possibilities Offered by Digitalization (Preprint)

Eberle¹,

Stichling²,

Löhnert³

2020

Preprint

View full text Add to dashboard Cite

BACKGROUND Increasing prevalence of diabetes mellitus (DM) and associated morbidity, worldwide, justify the need to create new approaches and strategies for diabetic therapy. Therefore, the ongoing digitalization offers novel opportunities. OBJECTIVE The aim of this paper is to give an updated overview of available diabetes technologies and possibilities and novel insights in diabetes therapy 4.0. METHODS A scoping review was carried out. A search for literature was performed in electronic databases (MEDLINE (PubMed), Cochrane Library, EMBASE, CINAHL and Web of Science). The results were categorized by the type of technology that was presented. RESULTS Different types of technology (glucose monitoring systems, insulin-pens, insulin-pumps, closed-loop systems, mHealth-apps, telemedicine and electronic medical records) may help to improve diabetes treatment. The improvements affect glycemic control primarily. But, they also help to increase autonomy and quality of life of people who were diagnosed with DM. CONCLUSIONS Diabetes technologies developed fast over the last years and offer novel insights and a chance in diabetes therapy to improve and individualize diabetes treatment. Challenges that need to be addressed in the next years relate to data security, interoperability and the creation of standards. CLINICALTRIAL Not applicable.

show abstract

Structure and Characteristics of Diabetes Self-management Applications

Cited by 15 publications

References 36 publications

Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review

Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review

The Use of mHealth in Orthopedic Surgery: A Scoping Review

Diabetology 4.0: Scoping Review of Novel Insights and Possibilities Offered by Digitalization (Preprint)

Contact Info

Product

Resources

About